| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-042714 |
| cik | 1560293 |
| name | TENON MEDICAL, INC. |
| sic | 3841 |
| countryba | US |
| stprba | CA |
| cityba | LOS GATOS |
| zipba | 95032 |
| bas1 | 104 COOPER CT. |
| bas2 | |
| baph | (408) 649-5760 |
| countryma | US |
| stprma | CA |
| cityma | LOS GATOS |
| zipma | 95032 |
| mas1 | 104 COOPER CT. |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 455574718 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 16:51:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0240286-10q_tenon_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042714 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10311000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Cost Of Revenue | 403000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Deferred Costs | 431000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | General And Administrative Expense | 1926000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -29000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Interest Expense Nonoperating | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Nonoperating Income Expense | -70000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Operating Expenses | 3976000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Operating Lease Liability Current | 287000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20240229 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Outstanding | 256968.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Outstanding | 86454.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20240331 | Proceeds From Issuance Or Sale Of Equity | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20241231 | Retained Earnings Accumulated Deficit | -68746000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Selling And Marketing Expense | 1381000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Shares Outstanding | 256968.0000 | shares | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | 3300000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | -46000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042714 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3597.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3597.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Accounts Payable Current | 369000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Accounts Receivable Net Current | 886000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Accrued Sales Commission Current | 303000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1018000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Cash And Cash Equivalents At Carrying Value | 10311000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240229 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20211031 | Common Stock Shares Issued | 4445.0000 | shares | 0 | us-gaap/2025 | Type Of Arrangement= Sales Representative Agreement; | ||
| 0001213900-25-042714 | 20250331 | Common Stock Value | 8000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Comprehensive Income Net Of Tax | -3530000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Cost Of Revenue | 249000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Earnings Per Share Basic | -1.0100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Earnings Per Share Diluted | -10.0200 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Operating Lease Liability | -61000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Cash Provided By Used In Investing Activities | -119000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Cash Provided By Used In Operating Activities | -2338000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Operating Income Loss | -3506000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Operating Lease Liability Noncurrent | 141000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Payments To Acquire Property Plant And Equipment | 119000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Preferred Stock Value | 3300000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Property Plant And Equipment Net | 752000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20210531 | Selling And Marketing Expense | 880000.0000 | USD | 0 | us-gaap/2025 | Type Of Arrangement= Sales Representative Agreement; | ||
| 0001213900-25-042714 | 20241231 | Shares Outstanding | 86454.0000 | shares | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | 3300000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | 9376000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | -58649000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Issuance Of Series A Preferred Stock And Warrants Net Of Issuance Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240831 | Stock Issued During Period Shares New Issues | 86454.0000 | shares | 0 | us-gaap/2025 | Agreement= Purchase Agreement; Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares New Issues | 733500.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; Type Of Arrangement= Two Thousand Twenty Five Securities Purchase Agreements; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares New Issues | 1271500.0000 | shares | 0 | us-gaap/2025 | Type Of Arrangement= Two Thousand Twenty Five Securities Purchase Agreements; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares New Issues | 10000.0000 | shares | 1 | us-gaap/2025 | Short Term Debt Type= Equity Line Of Credit; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | shares | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | -110000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 2732000.0000 | USD | 1 | 0001213900-25-042714 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | USD | 1 | 0001213900-25-042714 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Warrant Modification Costs | 1402000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20241231 | Accrued Commissions Noncurrent | 1862000.0000 | USD | 0 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20241231 | Additional Paid In Capital | 70962000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Additional Paid In Capital | 77978000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 872000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 872000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Assets | 13394000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Assets Current | 11990000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Common Stock Shares Authorized | 130000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20220430 | Common Stock Shares Issued | 31235.0000 | shares | 0 | us-gaap/2025 | Type Of Arrangement= Sales Representative Agreement; | ||
| 0001213900-25-042714 | 20240331 | Gain Loss On Investments | 27000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Gain Loss On Investments | 61000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Accounts Payable | -167000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Liabilities Current | 1869000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Income Loss | -3576000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20250331 | Operating Lease Right Of Use Asset | 334000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 65000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Authorized | 491222.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Authorized | 4500000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Issued | 256968.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Issued | 86454.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Value | 3300000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Prepaid Expense And Other Assets Current | 206000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Proceeds From Issuance Of Common Stock | 1990000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Selling And Marketing Expense | 1647000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Share Based Compensation | 1018000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Shares Outstanding | 256968.0000 | shares | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Shares Outstanding | 7589965.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Shares Outstanding | 86454.0000 | shares | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | 77978000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | 452000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Deferred Deal Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 2005000.0000 | shares | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 2445700.0000 | shares | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | shares | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Issuance Of Series A Preferred Stock And Warrants Net Of Issuance Costs | 256968.0000 | shares | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 403.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | shares | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 461.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 3524000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | USD | 1 | 0001213900-25-042714 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 3000.0000 | USD | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042714 | 20240331 | Warrant Modification Costs | USD | 1 | 0001213900-25-042714 | ||||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20250331 | Accrued Liabilities Current | 911000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20241231 | Assets | 9843000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Assets Current | 8210000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 3776000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Deposits Assets Noncurrent | 51000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Gross Profit | 470000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Gross Profit | 323000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Accrued Liabilities | 390000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Inventories | 78000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Inventories | -11000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Inventory Net | 607000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Liabilities | 3872000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Liabilities | 4018000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | -3616000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20250331 | Operating Lease Liability Current | 295000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Operating Lease Liability Noncurrent | 65000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 46000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042714 | 20240331 | Other Nonoperating Expense | 63000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Payments Of Stock Issuance Costs | 224000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Retained Earnings Accumulated Deficit | -72362000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Share Based Compensation | 872000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | 3554000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | 254000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | -55073000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | 3300000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | 8000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Deferred Deal Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares New Issues | 73196.0000 | shares | 1 | us-gaap/2025 | Plan Name= Two Thousand And Twenty Two Equity Incentive Plan; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 2000.0000 | USD | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20241231 | Cash And Cash Equivalents At Carrying Value | 6535000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2428000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Common Stock Shares Issued | 7589965.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Conversion Of Stock Amount Issued1 | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20241231 | Liabilities And Stockholders Equity | 9843000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Liabilities And Stockholders Equity | 13394000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Cash Provided By Used In Financing Activities | 4371000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | -3616000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 60000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 46000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240229 | Preferred Stock Shares Authorized | 4500000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Authorized | 4500000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Proceeds From Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement | 3057000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20240331 | Proceeds From Issuance Of Convertible Preferred Stock | 2605000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Property Plant And Equipment Net | 698000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Provision For Doubtful Accounts | 10000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | 55897000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | 3624000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | USD | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 357.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 357.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Accounts Payable Current | 496000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Accounts Receivable Net Current | 863000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1018000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4388000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 6535000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Common Stock Shares Authorized | 130000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20210531 | Common Stock Shares Issued | 53757.0000 | shares | 0 | us-gaap/2025 | Type Of Arrangement= Sales Representative Agreement; | ||
| 0001213900-25-042714 | 20241231 | Common Stock Shares Issued | 3138804.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Common Stock Shares Outstanding | 3138804.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Common Stock Value | 3000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Conversion Of Stock Amount Issued1 | 1186000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Deposits Assets Noncurrent | 51000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | General And Administrative Expense | 1662000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Increase Decrease In Accounts Receivable | 63000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Operating Lease Liability | -68000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Interest Expense Nonoperating | 34000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Cash Provided By Used In Financing Activities | 6259000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Cash Provided By Used In Operating Activities | -2483000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Nonoperating Income Expense | 61000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Operating Income Loss | -3677000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Payments To Acquire Property Plant And Equipment | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Proceeds From Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement | USD | 1 | 0001213900-25-042714 | ||||
| 0001213900-25-042714 | 20250331 | Proceeds From Issuance Of Convertible Preferred Stock | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Proceeds From Issuance Or Sale Of Equity | 4010000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Provision For Doubtful Accounts | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20240331 | Reclassification Of Deferred Offering Costs To Additional Paidin Capital | 130000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20250331 | Reclassification Of Deferred Offering Costs To Additional Paidin Capital | 110000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20250331 | Research And Development Expense | 691000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20241231 | Shares Outstanding | 3138804.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20240331 | Stockholders Equity | 58973000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares New Issues | 140430.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares New Issues | shares | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042714 | 20250331 | Accrued Commissions Noncurrent | 1758000.0000 | USD | 0 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20241231 | Accrued Liabilities Current | 910000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Accrued Sales Commission Current | 493000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 1960000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Prepaid Expense And Other Assets Current | 186000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Common Stock Shares Outstanding | 7589965.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Comprehensive Income Net Of Tax | -3616000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Depreciation And Amortization | 42000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Accrued Liabilities | 87000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -20000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Inventory Net | 606000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Operating Expenses | 4000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Operating Lease Right Of Use Asset | 399000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042714 | 20240229 | Preferred Stock Shares Authorized | 491222.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Outstanding | 86454.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Value | 452000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20230430 | Proceeds From Issuance Of Common Stock | 5500000.0000 | USD | 0 | us-gaap/2025 | Trading Activity By Type= Atthe Market Offering Program; | ||
| 0001213900-25-042714 | 20240331 | Revenues | 719000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20231231 | Shares Outstanding | 325039.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Shares Outstanding | 465872.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20231231 | Stockholders Equity | 778000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | 70962000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240229 | Stock Issued During Period Shares New Issues | 172239.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock And Warrants; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares New Issues | shares | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | shares | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | -110000.0000 | USD | 1 | 0001213900-25-042714 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Deferred Deal Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 3522000.0000 | USD | 1 | 0001213900-25-042714 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | USD | 1 | 0001213900-25-042714 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | 1804000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value New Issues | 1804000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042714 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240229 | Common Stock Shares Authorized | 130000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042714 | 20250331 | Deferred Costs | 321000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Depreciation And Amortization | 100000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Earnings Per Share Basic | -10.0200 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Earnings Per Share Diluted | -1.0100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 46000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Accounts Payable | 127000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Increase Decrease In Accounts Receivable | 23000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Liabilities Current | 2195000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Income Loss | -3576000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 46000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Other Nonoperating Expense | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042714 | 20250331 | Payments Of Stock Issuance Costs | 808000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20240229 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Preferred Stock Shares Authorized | 491222.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Issued | 256968.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Issued | 86454.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Shares Outstanding | 256968.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-042714 | 20241231 | Preferred Stock Value | 452000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Series B Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Research And Development Expense | 669000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Revenues | 726000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20250331 | Shares Outstanding | 256968.0000 | shares | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20240331 | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | USD | 1 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | 5971000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | -68746000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20241231 | Stockholders Equity | 452000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Series B Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | -72362000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042714 | 20250331 | Stockholders Equity | 3300000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | ||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | shares | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Issuance Of Series A Preferred Stock And Warrants Net Of Issuance Costs | shares | 1 | 0001213900-25-042714 | Equity Components= Series B Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | shares | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | USD | 1 | 0001213900-25-042714 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 2735000.0000 | USD | 1 | 0001213900-25-042714 | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042714 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Series A Convertible Preferred Stock; | |||
| 0001213900-25-042714 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Convertible Preferred Stock | The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 0001213900-25-042714 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Other Nonoperating Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Other Nonoperating Expense | Amount of expense related to nonoperating activities, classified as other. |
| Proceeds From Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement | 0001213900-25-042714 | 1 | 0 | monetary | D | D | Proceeds From Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement | Represents the amount of cash inflow of gross proceeds from issuance of common stock, prefunded warrants and warrants under inducement agreement. |
| Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 0001213900-25-042714 | 1 | 0 | shares | D | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | Number of shares issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs. | |
| Stock Issued During Period Value Deferred Deal Costs | 0001213900-25-042714 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Deferred Deal Costs | Represent the amount of deferred deal costs. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Accrued Sales Commission Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Sales Commission, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Payments Of Stock Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Reclassification Of Deferred Offering Costs To Additional Paidin Capital | 0001213900-25-042714 | 1 | 0 | monetary | D | D | Reclassification Of Deferred Offering Costs To Additional Paidin Capital | Reclassification of deferred offering costs to additional paid-in capital. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Stock Issued During Period Shares Deferred Deal Costs | 0001213900-25-042714 | 1 | 0 | shares | D | Stock Issued During Period Shares Deferred Deal Costs | Number of shares deferred deal costs. | |
| Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 0001213900-25-042714 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | Represents the value of stock issued under issuance of common stock, prefunded warrants, and warrants, net of issuance costs. |
| Warrant Modification Costs | 0001213900-25-042714 | 1 | 0 | monetary | D | D | Warrant Modification Costs | Represent the amount of warrant modification costs. |
| Increase Decrease In Inventories | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Deposits Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. |
| Depreciation And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Stock And Warrants Issued During Period Value Preferred Stock And Warrants | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | Value of preferred stock and warrants for common stock issued. |
| Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Deferred Costs | us-gaap/2025 | 0 | 0 | monetary | I | D | Deferred Costs, Noncurrent | Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Inventory Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Conversion Of Stock Amount Issued1 | us-gaap/2025 | 0 | 0 | monetary | D | C | Conversion of Stock, Amount Issued | The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. |
| Gain Loss On Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Gain (Loss) on Investments | Amount of realized and unrealized gain (loss) on investment. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Or Sale Of Equity | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Provision For Doubtful Accounts | us-gaap/2025 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 0001213900-25-042714 | 1 | 0 | shares | D | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | Represents the number of shares issued under issuance of common stock, prefunded warrants, and warrants, net of issuance costs. | |
| Stock Issued During Period Shares Issuance Of Series A Preferred Stock And Warrants Net Of Issuance Costs | 0001213900-25-042714 | 1 | 0 | shares | D | Stock Issued During Period Shares Issuance Of Series APreferred Stock And Warrants Net Of Issuance Costs | Represents the number of shares issued under issuance of Series A preferred stock and warrants, net of issuance costs. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Accrued Commissions Noncurrent | 0001213900-25-042714 | 1 | 0 | monetary | I | C | Accrued Commissions Noncurrent | Accrued commissions non current. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042714 | 6 | 10 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2025 | Inventory | 1 |
| 0001213900-25-042714 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-042714 | 2 | 10 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net | 0 |
| 0001213900-25-042714 | 2 | 11 | BS | 0 | H | Inventory Net | us-gaap/2025 | Inventory, net | 0 |
| 0001213900-25-042714 | 2 | 12 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-042714 | 2 | 13 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-042714 | 2 | 14 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001213900-25-042714 | 2 | 15 | BS | 0 | H | Deposits Assets Noncurrent | us-gaap/2025 | Deposits | 0 |
| 0001213900-25-042714 | 2 | 16 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use asset | 0 |
| 0001213900-25-042714 | 2 | 17 | BS | 0 | H | Deferred Costs | us-gaap/2025 | Deferred offering costs | 0 |
| 0001213900-25-042714 | 2 | 18 | BS | 0 | H | Assets | us-gaap/2025 | TOTAL ASSETS | 0 |
| 0001213900-25-042714 | 2 | 21 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042714 | 2 | 22 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-042714 | 2 | 23 | BS | 0 | H | Accrued Sales Commission Current | us-gaap/2025 | Current portion of accrued commissions | 0 |
| 0001213900-25-042714 | 2 | 24 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Current portion of operating lease liability | 0 |
| 0001213900-25-042714 | 2 | 25 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-042714 | 2 | 26 | BS | 0 | H | Accrued Commissions Noncurrent | 0001213900-25-042714 | Accrued commissions, net of current portion | 0 |
| 0001213900-25-042714 | 2 | 27 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liability, net of current portion | 0 |
| 0001213900-25-042714 | 2 | 28 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-042714 | 2 | 29 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and contingencies (Note 7) | 0 |
| 0001213900-25-042714 | 2 | 31 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Convertible preferred stock, value | 0 |
| 0001213900-25-042714 | 2 | 32 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.001 par value; 130,000,000 shares authorized at March 31, 2025 and December 31, 2024; 7,589,965 and 3,138,804 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001213900-25-042714 | 2 | 33 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-042714 | 2 | 34 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-042714 | 2 | 35 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001213900-25-042714 | 2 | 36 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0001213900-25-042714 | 3 | 7 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in Dollars per share) | 0 |
| 0001213900-25-042714 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized | 0 |
| 0001213900-25-042714 | 3 | 9 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued | 0 |
| 0001213900-25-042714 | 3 | 10 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-042714 | 3 | 11 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-042714 | 3 | 12 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-042714 | 3 | 13 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-042714 | 3 | 14 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-042714 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | Revenue | 0 |
| 0001213900-25-042714 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
| 0001213900-25-042714 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross Profit | 0 |
| 0001213900-25-042714 | 4 | 5 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001213900-25-042714 | 4 | 6 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
| 0001213900-25-042714 | 4 | 7 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001213900-25-042714 | 4 | 8 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total Operating Expenses | 0 |
| 0001213900-25-042714 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from Operations | 0 |
| 0001213900-25-042714 | 4 | 11 | IS | 0 | H | Gain Loss On Investments | us-gaap/2025 | Gain on investments | 0 |
| 0001213900-25-042714 | 4 | 12 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | Interest expense | 1 |
| 0001213900-25-042714 | 4 | 13 | IS | 0 | H | Other Nonoperating Expense | us-gaap/2025 | Other expense | 1 |
| 0001213900-25-042714 | 4 | 14 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total Other Income (Expense), net | 0 |
| 0001213900-25-042714 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net Loss | 0 |
| 0001213900-25-042714 | 4 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic (in Dollars per share) | 0 |
| 0001213900-25-042714 | 4 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted (in Dollars per share) | 0 |
| 0001213900-25-042714 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Basic (in Shares) | 0 |
| 0001213900-25-042714 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Diluted (in Shares) | 0 |
| 0001213900-25-042714 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-042714 | 4 | 24 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | Foreign currency translation adjustment | 0 |
| 0001213900-25-042714 | 4 | 25 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Total Comprehensive Loss | 0 |
| 0001213900-25-042714 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-042714 | 5 | 12 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 13 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001213900-25-042714 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of common stock, net of issuance costs | 0 |
| 0001213900-25-042714 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of common stock, net of issuance costs (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 16 | EQ | 0 | H | Stock And Warrants Issued During Period Value Preferred Stock And Warrants | us-gaap/2025 | Issuance of Series A preferred stock and warrants, net of issuance costs | 0 |
| 0001213900-25-042714 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Issuance Of Series A Preferred Stock And Warrants Net Of Issuance Costs | 0001213900-25-042714 | Issuance of Series A preferred stock and warrants, net of issuance costs (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 0001213900-25-042714 | Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs | 0 |
| 0001213900-25-042714 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement Net | 0001213900-25-042714 | Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 0001213900-25-042714 | Issuance of common stock, prefunded warrants, and warrants, net of issuance costs | 0 |
| 0001213900-25-042714 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Issuance Of Common Stock Prefunded Warrants And Warrants Net Of Issuance Costs | 0001213900-25-042714 | Issuance of common stock, prefunded warrants, and warrants, net of issuance costs (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2025 | Release of restricted stock units | 0 |
| 0001213900-25-042714 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | Release of restricted stock units (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 24 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | Other comprehensive income | 0 |
| 0001213900-25-042714 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Value Deferred Deal Costs | 0001213900-25-042714 | Deferred deal costs | 0 |
| 0001213900-25-042714 | 5 | 26 | EQ | 0 | H | Stock Issued During Period Shares Deferred Deal Costs | 0001213900-25-042714 | Deferred deal costs (in Shares) | 0 |
| 0001213900-25-042714 | 5 | 27 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-042714 | 5 | 28 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-042714 | 5 | 29 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-042714 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-042714 | 6 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001213900-25-042714 | 6 | 5 | CF | 0 | H | Depreciation And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001213900-25-042714 | 6 | 6 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2025 | Provision for credit losses on accounts receivable | 0 |
| 0001213900-25-042714 | 6 | 7 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | Amortization of operating right-of-use asset | 0 |
| 0001213900-25-042714 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable | 1 |
| 0001213900-25-042714 | 6 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
| 0001213900-25-042714 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042714 | 6 | 13 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-042714 | 6 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Operating lease liability | 0 |
| 0001213900-25-042714 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-042714 | 6 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
| 0001213900-25-042714 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
| 0001213900-25-042714 | 6 | 20 | CF | 0 | H | Proceeds From Issuance Or Sale Of Equity | us-gaap/2025 | Gross proceeds from issuance of common stock, prefunded warrants and warrants | 0 |
| 0001213900-25-042714 | 6 | 21 | CF | 0 | H | Proceeds From Issuance Of Common Stock Prefunded Warrants And Warrants Under Inducement Agreement | 0001213900-25-042714 | Gross proceeds from issuance of common stock, prefunded warrants and warrants under inducement agreement | 0 |
| 0001213900-25-042714 | 6 | 22 | CF | 0 | H | Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2025 | Proceeds from issuance of Series A convertible preferred stock | 0 |
| 0001213900-25-042714 | 6 | 23 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of common stock | 0 |
| 0001213900-25-042714 | 6 | 24 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2025 | Offering costs | 1 |
| 0001213900-25-042714 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001213900-25-042714 | 6 | 26 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Effect of foreign currency translation on cash flow | 0 |
| 0001213900-25-042714 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net Increase in Cash and Cash Equivalents | 0 |
| 0001213900-25-042714 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and Cash Equivalents at Beginning of Period | 0 |
| 0001213900-25-042714 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and Cash Equivalents at End of Period | 0 |
| 0001213900-25-042714 | 6 | 31 | CF | 0 | H | Warrant Modification Costs | 0001213900-25-042714 | Warrant modification costs | 0 |
| 0001213900-25-042714 | 6 | 32 | CF | 0 | H | Conversion Of Stock Amount Issued1 | us-gaap/2025 | Preferred stock issued upon conversion of debt and accrued interest | 0 |
| 0001213900-25-042714 | 6 | 33 | CF | 0 | H | Reclassification Of Deferred Offering Costs To Additional Paidin Capital | 0001213900-25-042714 | Reclassification of deferred offering costs to additional paid-in capital | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |